Abstracts - faqs.org

Abstracts

Science and technology

Search abstracts:
Abstracts » Science and technology

Old MacDonald's pharm

Article Abstract:

The European Medicines Evaluation Agency (EMEA) approved to make the drug Atryn, which can make the blood flow, the human protein antithrombin that inhibits clotting, the first human protein made by a transgenic animal for commercial production. The market for patients with hereditary antithrombin deficiency is only about $50 million in Europe and the US combined but Atryn could find therapeutic uses for burns, coronary artery bypass surgery, sepsis and bone marrow transplants, for upto a $700-million market worldwide.

Author: Choi, Charles Q.
Publisher: Scientific American, Inc.
Publication Name: Scientific American
Subject: Science and technology
ISSN: 0036-8733
Year: 2006
Government regulation, Blood Clot Dissolvers, Biological products industry, Licensing, certification and accreditation, Fibrinolytic agents, Thrombolytic drugs, European Agency for the Evaluation of Medicinal Products, GTC Biotherapeutics Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Stem cell imperative

Article Abstract:

Embryonic stem cells are able to become any other cell in the body and a capability researches hope it can be used to cure organs damaged by disease. International stem cell company Stem Cell Sciences aims at developing stem cell therapy to treat diabetes and Parkinson's disease.

Author: Choi, Charles Q.
Publisher: Scientific American, Inc.
Publication Name: Scientific American
Subject: Science and technology
ISSN: 0036-8733
Year: 2005
Australia, Science & research, Research, Biotechnology industry, Biotechnology industries, Structure, Embryonic stem cells, Stem Cell Sciences

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


New movement in Parkinson's

Article Abstract:

Genetic and cellular discoveries point to improved treatments for the neurological disorder called Parkinson. Parkinson's disease that was described in the early 1880s by British physician James Parkinson as 'shaking palsy,' is among the most prevalent neurological disorders.

Author: Lozano, Andres M., Kalia, Suneil K.
Publisher: Scientific American, Inc.
Publication Name: Scientific American
Subject: Science and technology
ISSN: 0036-8733
Year: 2005
United States, Brain research

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Product development, Care and treatment, Parkinson's disease, Parkinson disease, Antiparkinsonian agents, Antiparkinson agents
Similar abstracts:
  • Abstracts: Missing movement. Wait a second. Jam session
  • Abstracts: Design/build exposure: 'implied' duties. Firm mounts defense against 'Constructability' suit. The law
  • Abstracts: On the road to fuel-cell cars. Rotor in motor
  • Abstracts: Observation decks at Rockefeller Centre reopen after infrastructure changes. Structural engineering: Mock-up help engineers test features of New York Times building
  • Abstracts: California Water District receives patent for water treatment technology. Transportation: Caltrans to expand hot lanes near San Diego
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.